Tag Archives: Prof Peter White

Design of PACE trial

Posted on 11/20/2015 by wames

Abstract: Background: Clinical trials require large monetary and time commitments and should provide information on both whether and how treatments work. Treatment mechanisms can be studied using mediation analysis, allowing refinement of treatments. Mediation studies often use only single contemporaneous measures of mediator and … Continue reading →

Posted in News | Tagged , , , | Comments Off on Design of PACE trial

Why has the PACE Study’s “Sister Trial” been “Disappeared” and Forgotten?

Posted on 11/11/2015 by wames

David Tuller continues his analysis of research about treatments for CFS with an examination of the FINE trial.  A summary has been compiled by MEAction. Virology blog: Trial By Error, Continued: Why has the PACE Study’s “Sister Trial”been “Disappeared” and Forgotten? [9 … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , | Comments Off on Why has the PACE Study’s “Sister Trial” been “Disappeared” and Forgotten?

PACE trial researchers respond to David Tuller

Posted on 11/02/2015 by wames

David Tuller’s three-installment investigation of the PACE trial for CFS, Trial By Error, received much attention in the press. Although the PACE researchers declined David’s efforts to interview them, they subsequently requested the right to reply. Virology blog posted the response of Professors … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on PACE trial researchers respond to David Tuller

White on Pathways to Prevention and PACE

Posted on 07/06/2015 by wames

Comment published on 30 June 2015 in the Annals of Internal Medicine on the following article: Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome By PD White, MD, DJ Clauw, MD, JWM van der Meer, MD, R Moss-Morris, PhD, RR Taylor, PhD … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on White on Pathways to Prevention and PACE